{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:46:56Z","timestamp":1791704816515,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017413","name":"Innovation Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017413","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018919","name":"Pengcheng Laboratory","doi-asserted-by":"publisher","award":["SQ2510300009"],"award-info":[{"award-number":["SQ2510300009"]}],"id":[{"id":"10.13039\/100018919","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Hainan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["826MS0152"],"award-info":[{"award-number":["826MS0152"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2024-I2M-C&T-B-061"],"award-info":[{"award-number":["2024-I2M-C&T-B-061"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.tranon.2026.103060","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:18:51Z","timestamp":1790900331000},"page":"103060","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A dual-tower multimodal framework with feature quality enhancement for predicting pathological complete response after neoadjuvant chemotherapy in breast cancer: a multicenter study"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1220-4196","authenticated-orcid":false,"given":"Yongxi","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-0368","authenticated-orcid":false,"given":"Peng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.103060_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2026.103060_bib0002","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","article-title":"De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017","volume":"28","author":"Curigliano","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tranon.2026.103060_bib0003","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/annonc\/mdx397","article-title":"Revisiting the definition of estrogen receptor positivity in HER2-negative primary breast cancer","volume":"28","author":"Fujii","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.tranon.2026.103060_bib0004","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.tranon.2026.103060_bib0005","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1200\/JCO.22.02241","article-title":"Pathologic complete response and individual patient prognosis after neoadjuvant chemotherapy plus anti-human epidermal growth factor receptor 2 therapy of human epidermal growth factor receptor 2-positive early breast cancer","volume":"41","author":"van Mackelenbergh","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.103060_bib0006","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaoncol.2020.2535","article-title":"Association of event-free and distant recurrence-free survival with individual-level pathologic complete response in neoadjuvant treatment of stages 2 and 3 breast cancer: three-yea r follow-up analysis for the i-spy2 adaptively randomized clinical trial","volume":"6","author":"Yee","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.tranon.2026.103060_bib0007","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ejso.2006.12.006","article-title":"The surgical management of patients who achieve a complete pathological response after primary chemotherapy for locally advanced breast cancer","volume":"33","author":"Clouth","year":"2007","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.tranon.2026.103060_bib0008","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1148\/radiol.220389","article-title":"Prospective evaluation of ultrafast breast MRI for predicting pathologic response after neoadjuvant therapies","volume":"305","author":"Ramtohul","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.tranon.2026.103060_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48465-x","article-title":"Prediction of treatment response to neoadjuvant chemotherapy for breast cancer via early changes in tumor heterogeneity captured by DCE-MRI registration","volume":"9","author":"Jahani","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2026.103060_bib0010","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jnci\/djs528","article-title":"Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy","volume":"105","author":"Marinovich","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.tranon.2026.103060_bib0011","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98408-8","article-title":"Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer","volume":"11","author":"Joo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2026.103060_bib0012","article-title":"Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study","volume":"58","author":"Huang","year":"2023","journal-title":"E Clin.Med."},{"key":"10.1016\/j.tranon.2026.103060_bib0013","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaf209","article-title":"MMsurv: a multimodal multi-instance multi-cancer survival prediction model integrating pathological images, clinical information, and sequencing data","volume":"26","author":"Yang","year":"2025","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.tranon.2026.103060_bib0014","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.csbj.2021.12.028","article-title":"Prediction of HER2-positive breast cancer recurrence and metastasis risk from histopathological images and clinical information via multimodal deep learning","volume":"20","author":"Yang","year":"2022","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.tranon.2026.103060_bib0015","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1038\/s41467-024-53450-8","article-title":"An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancer","volume":"15","author":"Gao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.103060_bib0017","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71221","article-title":"Interpretable machine learning for predicting neoadjuvant chemotherapy response in breast cancer using the baseline clinical and pathological characteristics","volume":"14","author":"Fang","year":"2025","journal-title":"Cancer Med."},{"key":"10.1016\/j.tranon.2026.103060_bib0018","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2541316","article-title":"Machine learning and SHAP value interpretation for predicting the response to neoadjuvant chemotherapy and long-term clinical outcomes in Chinese female breast cancer","volume":"57","author":"Yuan","year":"2025","journal-title":"Ann. Med."},{"key":"10.1016\/j.tranon.2026.103060_bib0019","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbaf580","article-title":"Deep learning-based fusion of nuclear segmentation features for microsatellite instability and tumor mutational burden prediction in digestive tract cancers: a multicenter validation study","volume":"26","author":"Zhang","year":"2025","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.tranon.2026.103060_bib0020","article-title":"A Dynamic Contrast-Enhanced MRI-Based Vision Transformer Model for Distinguishing HER2-Zero, -Low, and -Positive Expression in Breast Cancer and Exploring Model Interpretability","volume":"12","author":"Zhang","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.tranon.2026.103060_bib0021","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41586-021-04278-5","article-title":"Multi-omic machine learning predictor of breast cancer therapy response","volume":"601","author":"Sammut","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2026.103060_bib0022","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/jamaoncol.2015.6478","article-title":"The neo-bioscore update for staging breast cancer treated with neoadjuvant chemotherapy: incorporation of prognostic biologic factors into staging after treatment","volume":"2","author":"Mittendorf","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.tranon.2026.103060_bib0023","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1158\/1078-0432.CCR-12-3628","article-title":"Ki67 measured after neoadjuvant chemotherapy for primary breast cancer","volume":"19","author":"von Minckwitz","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2026.103060_bib0024","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1186\/s12885-023-11368-2","article-title":"Impact of estrogen receptor expression level on response to neoadjuvant chemotherapy and prognosis in HER2-negative breast cancers","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2026.103060_bib0025","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.22.02363","volume":"41","author":"Squifflet","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.103060_bib0026","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/SLA.0000000000002953","article-title":"The clinical significance of breast-only and node-only pathologic complete response (pcr) after neoadjuvant chemotherapy (nact): a review of 20,000 breast cancer patients in the national cancer data base (NCDB)","volume":"268","author":"Fayanju","year":"2018","journal-title":"Ann. Surg."},{"key":"10.1016\/j.tranon.2026.103060_bib0027","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: asco\/cap guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.tranon.2026.103060_bib0016","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational Radiomics System to Decode the Radiographic Phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:30:52Z","timestamp":1791703852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":27,"alternative-id":["S1936523326003967"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103060","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A dual-tower multimodal framework with feature quality enhancement for predicting pathological complete response after neoadjuvant chemotherapy in breast cancer: a multicenter study","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103060"}}